RSV: Management of the acute episode.
Bronchiolitis is the most common lower respiratory tract infection in infants and is responsible for the majority of paediatric hospital admissions in the winter. Despite significant advances in pharmacotherapy, the management of infants with bronchiolitis has changed little over the years from supplemental oxygen and good fluid management. This paper reviews current treatment options for bronchiolitis, including the use of bronchodilators, adrenaline, steroids and ribavirin. More recent advances, including immunotherapy and intensive care, are discussed.
Hodge
D
D
Department of Paediatrics and Child Health, University of Leeds, The General Infirmary at Leeds, D Floor, Clarendon Wing, Belmont Grove, Leeds, LS2 9NS, UK.
Chetcuti
P A
PA
D000208:Acute Disease; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D001990:Bronchiolitis, Viral / Q000175:diagnosis / Q000628:therapy* / Q000821:virology*; D001993:Bronchodilator Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D004837:Epinephrine / Q000627:therapeutic use; D005440:Fluid Therapy; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D010092:Oximetry; D010102:Oxygen Inhalation Therapy; D018357:Respiratory Syncytial Virus Infections / Q000175:diagnosis / Q000628:therapy*
D000305:Adrenal Cortex Hormones; D000998:Antiviral Agents; D001993:Bronchodilator Agents; D004837:Epinephrine